Gastrointestinal stromal tumors are rare tumors of the gastrointestinal tract. Gastrointestinal stromal tumors involving the rectum are uncommon. We describe a case of a 43-year-old female with a gastrointestinal stromal tumor of the rectum who declined abdominoperineal resection. Neoadjuvant treatment with imatinib decreased her tumor size, permitting sphincter-sparing transanal excision. She had no evidence of disease for 24 months postoperatively until she recurred with lung metastases. Microdissection genoty** of the recurrent lesion revealed a deletion in exon 11. Further mutational analysis showed that her metastatic lesion was concordant with her primary rectal lesion, suggesting that systemic micrometastasis was previously present at initial diagnosis. Deletion in exon 11 predicts for response with imatinib treatment and is associated with a longer event-free and overall survival. Current studies are underway that may help us optimize the treatment for patients with gastrointestinl stromal tumors.
Similar content being viewed by others
REFERENCES
J Berman TJ O’Leary (2001) ArticleTitleGastrointestinal stromal tumor workshop Hum Pathol 32 578–82 Occurrence Handle10.1053/hupa.2001.25484 Occurrence Handle1:STN:280:DC%2BD3MznsVKluw%3D%3D Occurrence Handle11431711
S Dacic SD Finkelstein E Sasatomi PA Swalsky SA Yousem (2002) ArticleTitleMolecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based alleloty** Am J Surg Pathol 26 510–6 Occurrence Handle10.1097/00000478-200204000-00015 Occurrence Handle11914631
SD Finkelstein R Przygodzki VE Pricolo et al. (1996) ArticleTitlePrediction of biologic aggressiveness in colorectal cancer by p53/K-ras-2 topographic genoty** Mol Diagn 1 5–28 Occurrence Handle1:CAS:528:DyaK28XntlKgsL4%3D Occurrence Handle10330194
CDM Fletcher JJ Berman C Corless et al. (2002) ArticleTitleDiagnosis of gastrointestinal stromal tumors: a consensus approach Hum Pathol 33 459–65 Occurrence Handle12094370
M Miettinen M Sarlomo-Rikala J Lasota (1998) ArticleTitleGastrointestinal stromal tumours Ann Chir Gynaecol 87 278–81 Occurrence Handle1:STN:280:DyaK1M7gvV2itg%3D%3D Occurrence Handle9891765
M Miettinen M Furlong M Sarlomo-Rikala A Burke LH Sobin J Lasota (2001) ArticleTitleGastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus Am J Surg Path 25 1121–33 Occurrence Handle10.1097/00000478-200109000-00002 Occurrence Handle1:STN:280:DC%2BD3MnjsFajsg%3D%3D Occurrence Handle11688571
EM Connolly E Gaffney JV Reynolds (2003) ArticleTitleGastrointestinal stromal tumours Br J Surg 90 1178–86 Occurrence Handle10.1002/bjs.4352 Occurrence Handle1:STN:280:DC%2BD3svltl2itw%3D%3D Occurrence Handle14515284
Y Hama H Okizuka K Odajima M Hayakawa S Kusano (2001) ArticleTitleGastrointestinal stromal tumor of the rectum Eur Radiol 11 216–9 Occurrence Handle10.1007/s003300000615 Occurrence Handle1:STN:280:DC%2BD3M3ksVakug%3D%3D Occurrence Handle11218017
Y Shibata U Tadashi H Seki N Yagihashi (2001) ArticleTitleGastrointestinal stromal tumour of the rectum Eur J Gastroenterol Hepatol 13 283–6 Occurrence Handle10.1097/00042737-200103000-00012 Occurrence Handle1:STN:280:DC%2BD3Mzitl2rtg%3D%3D Occurrence Handle11293450
M Sarlomo-Rikala AJ Kovatich A Barusevicius M Miettinen (1998) ArticleTitleCD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34 Mod Pathol 11 728–34 Occurrence Handle1:STN:280:DyaK1czosFCmtg%3D%3D Occurrence Handle9720500
S Hirota K Isozaki Y Moriyama et al. (1998) ArticleTitleGain-of-function mutations of c-kit in human gastrointestinal stromal tumors Science 279 577–80 Occurrence Handle10.1126/science.279.5350.577 Occurrence Handle1:CAS:528:DyaK1cXotVyhsw%3D%3D Occurrence Handle9438854
ML Lux BP Rubin TL Biase et al. (2000) ArticleTitleKIT extracellular and kinase domain mutations in gastrointestinal stromal tumors Am J Pathol 156 791–5 Occurrence Handle1:CAS:528:DC%2BD3c**tVerur0%3D Occurrence Handle10702394
MC Heinrich CL Corless GD Demetri et al. (2003) ArticleTitleKinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor J Clin Oncol 21 4342–49 Occurrence Handle1:CAS:528:DC%2BD2cXpsVWqu7Y%3D Occurrence Handle14645423
H Joensuu PJ Roberts M Sarlomo-Rikala et al. (2001) ArticleTitleEffect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor N Engl J Med 344 1052–56 Occurrence Handle1:STN:280:DC%2BD3M3gvVekuw%3D%3D Occurrence Handle11287975
GD Demetri M von Mehren CD Blanke et al. (2002) ArticleTitleEfficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors N Engl J Med 347 472–80 Occurrence Handle10.1056/NEJMoa020461 Occurrence Handle1:CAS:528:DC%2BD38XmtV2nt7s%3D Occurrence Handle12181401
PC Wu A Langerman CW Ryan J Hart S Swiger MC Posner (2003) ArticleTitleSurgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era Surgery 134 656–65 Occurrence Handle10.1016/S0039-6060(03)00314-3 Occurrence Handle14605627
Protocol RTOG-S. 0132. Phase II study of neoadjuvant/adjuvant imatinib mesylate in patients with primary or recurrent malignant gastrointestinal stromal tumor. Available at: http://www.cancer.gov. Accessed May 14, 2004
Protocol ACOSOG-Z. 9001. Phase III randomized study of adjuvant imatinib mesylate in patients with resected primary gastrointestinal stromal tumor. Available at: http://www.cancer.gov. Accessed May 14, 2004
Author information
Authors and Affiliations
Corresponding author
Additional information
Reprints are not available.
About this article
Cite this article
Lo, S., Papachristou, G., Finkelstein, S. et al. Neoadjuvant Imatinib in Gastrointestinal Stromal Tumor of the Rectum: Report of a Case. Dis Colon Rectum 48, 1316–1319 (2005). https://doi.org/10.1007/s10350-004-0922-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-004-0922-3